JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)			1 Months Ended			3 Months Ended	6 Months Ended	12 Months Ended	59 Months Ended
	Aug. 11, 2017	Aug. 03, 2012	Aug. 25, 2016	Jun. 01, 2016	Mar. 31, 2016	Mar. 31, 2017	Jun. 30, 2017	Dec. 31, 2016	Jun. 30, 2017	Aug. 31, 2017	Jul. 14, 2017	Aug. 31, 2016
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 6,000,000					$ 6,000,000		$ 6,000,000		$ 1,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares)		600,000
Joint Venture Investments In Non Voting Preferred Ownership Units		5,000,000
Development Activities Monthly Fee		$ 63,000
Joint Venture, Operating Expenses, Inter Company Transactions							409,000		8,881,000
Joint Venture, Operating Expenses Allocated To Company							409,000		7,269,000
Percentage Of Non Royalty Income			5.00%
Conversion of Stock, Shares Converted					1,500,000
Conversion of Stock, Shares Issued					120,000
Joint Venture Method Investment Ownership Percentage		60.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			33,088
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 10.70
Management Fees				$ 80,000
Professional Fees				$ 10,000
Class Of Warrant Or Right Expiration Terms			10 years
Series B1 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity			$ 946,000									$ 946,000
Joint Venture Method Investment Ownership Percentage			59.30%
Preferred Stock,Converted Basis Post-Closing Common Stock ,Percentage			7.80%
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs			$ 1,012,000
Proceeds from Issuance of Preferred Stock and Preference Stock			946,000					$ 946,000
Payments of Stock Issuance Costs			$ 66,000
Stock Issued During Period, Shares, New Issues			94,537
Professional Fees								60,000
Management Fee Expense								300,000
Series B1 And B2 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage						62.20%
Revolving Credit Facility [Member]
Related Party Transaction [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 1,600,000
Long-term Line of Credit							1,600,000		1,600,000
Common Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity							$ 0		$ 0
Preferred Stock [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent							100.00%		100.00%
Noncontrolling Interest [Member]
Related Party Transaction [Line Items]
Noncash or Part Noncash Acquisition, Other Liabilities Assumed									$ 667,000
Subsequent Event [Member]
Related Party Transaction [Line Items]
Conversion of Stock, Shares Converted	3,500,000
Accrued Professional Fees										$ 20,000
Conversion of Stock, Amount Converted	$ 3,500,000
Conversion of Stock, Amount Issued	$ 1,000,000
Subsequent Event [Member] | Management Fees [Member]
Related Party Transaction [Line Items]
Other Commitments, Future Minimum Payments, Remainder of Fiscal Year										150,000
Other Commitment, Due in Second Year										$ 150,000
Subsequent Event [Member] | Series B2 Preferred Stock [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, Acquisitions	93,458
Stock Issued During Period, Value, Acquisitions	$ 1,000,000
Maximum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage					64.00%
Minimum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage					60.00%
Exclusive License Agreement [Member]
Related Party Transaction [Line Items]
Percentage Of Royalty Payment			3.00%
Annual Maintenance Payments			$ 25,000
Exclusive License Agreement [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Milestone Payments			500,000
Royalty Expense			1,000,000
Exclusive License Agreement [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Milestone Payments			50,000
Royalty Expense			$ 500,000
Lipimetix [Member]
Related Party Transaction [Line Items]
Joint Venture Investments Common Ownership Units, Co-venture (in shares)		400,000
Ownership Percentage Co-venture		40.00%					36.00%
Noncash or Part Noncash Acquisition, Other Liabilities Assumed							$ 667,000
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed), Total							$ 378,000
Lipimetix [Member] | Ownership As Converted [Member]
Related Party Transaction [Line Items]
Ownership Percentage Co-venture							30.60%
Voting Common Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 1,000,000
Non Voting Preferred Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 5,000,000